- Home
- TC vs SCNX Comparison
TC vs SCNX Comparison
Compare TC & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- SCNX
- Stock Information
- Founded
- TC 2010
- SCNX 2010
- Country
- TC China
- SCNX United States
- Employees
- TC N/A
- SCNX N/A
- Industry
- TC Business Services
- SCNX Other Pharmaceuticals
- Sector
- TC Consumer Discretionary
- SCNX Health Care
- Exchange
- TC Nasdaq
- SCNX Nasdaq
- Market Cap
- TC 31.8M
- SCNX 31.5M
- IPO Year
- TC 2018
- SCNX 2020
- Fundamental
- Price
- TC $17.40
- SCNX $0.59
- Analyst Decision
- TC
- SCNX
- Analyst Count
- TC 0
- SCNX 0
- Target Price
- TC N/A
- SCNX N/A
- AVG Volume (30 Days)
- TC 8.0K
- SCNX 16.4M
- Earning Date
- TC 12-16-2025
- SCNX 11-13-2025
- Dividend Yield
- TC N/A
- SCNX N/A
- EPS Growth
- TC N/A
- SCNX N/A
- EPS
- TC N/A
- SCNX N/A
- Revenue
- TC $5,115,721.00
- SCNX $653,391.00
- Revenue This Year
- TC N/A
- SCNX N/A
- Revenue Next Year
- TC N/A
- SCNX N/A
- P/E Ratio
- TC N/A
- SCNX N/A
- Revenue Growth
- TC N/A
- SCNX 207.88
- 52 Week Low
- TC $9.20
- SCNX $0.46
- 52 Week High
- TC $39.00
- SCNX $8.72
- Technical
- Relative Strength Index (RSI)
- TC 53.77
- SCNX 44.06
- Support Level
- TC $15.75
- SCNX $0.50
- Resistance Level
- TC $18.10
- SCNX $0.62
- Average True Range (ATR)
- TC 1.17
- SCNX 0.06
- MACD
- TC -0.31
- SCNX -0.00
- Stochastic Oscillator
- TC 42.20
- SCNX 31.62
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.